IDENTIFICATION OF A NOVEL SIGNAL PATHWAY FOR NGF
IDENTIFICATION OF A NOVEL SIGNAL PATHWAY FOR NGF
批准号:
6627214
负责人:
RAYMOND B BIRGE
金额:
$27.64万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2003-12-31
关键词:
PC12 cells biological signal transduction cell adhesion cell growth regulation confocal scanning microscopy extracellular matrix gene induction /repression genetically modified animals immunofluorescence technique immunoprecipitation laboratory mouse metalloendopeptidases neurogenesis neurotrophic factors paxillin phosphorylation protein binding protein structure function protein tyrosine kinase receptor coupling regulatory gene tissue /cell culture transfection yeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nerve Growth Factor (NGF) is a polypeptide growth factor that plays a
critical role in the differentiation of immature neuroblasts and the
subsequent survival of a subpopulation of mature neurons in both the
peripheral and central nervous systems. NGF initiates its effects by
binding to TrkA, a receptor type tyrosine kinase that when activated,
initiates a signal transduction cascade resulting in Ras activation and
the induction of early response genes. NGF-induced neurite outgrowth
is also accompanied by extensive re-organization of the neuronal
cytoskeleton to initiate neurite extension of neurite processes. Indeed,
while the shape of filopodia and lamella in growth cones is largely
determined by the organization of the actin cytoskeleton, little is
known about how NGF and TrkA signaling is linked to the cytoskeleton.
Over the past few years, we have been studying the Crk adaptor protein
and its role during NGF-induced neuronal differentiation. Upon NGF
addition to PC12 cells or primary dorsal root ganglia neurons, c-Crk is
rapidly tyrosine phosphorylated at tyrosine 222. Interestingly,
overexpression of mutant c-Crk carrying a mutation at Y222 (c-CrkY222F)
impairs NGF-mediated neurite outgrowth in PC12 cells and abolishes TrkA-
induced tyrosine phosphorylation of the cytoskeletal protein Paxillin.
Our results indicate that Crk is involved in a novel aspect of TrkA
signaling to adhesion complexes, thereby regulating actin re-
organization and cell adhesion. In the present application, we shall
study the molecular mechanisms by which c-Crk couples the TrkA receptor
to the cytoskeleton, with the long-term goal to understand how NGF
promotes differentiation and survival. Specifically, we plan to: (i)
determine whether c-CrkY222F is a dominant negative c-Crk protein by
impairing NGF-induced cell adhesion, (ii) determine the circuitry
involved in NGF-induced tyrosine phosphorylation of c-Crk, (iii)
determine the relationship between NGF- and adhesion-induced tyrosine
phosphorylation of the c-Crk effector protein Paxillin, (iv) determine
the biological role of Paxillin during NGF-mediated responses, and (v)
determine the role of c-Crk during neuronal development using transgene
approaches.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Real-time fluorescent resonance energy transfer analysis to monitor drug resistance in chronic myelogenous leukemia.
实时荧光共振能量转移分析监测慢性粒细胞白血病的耐药性。
DOI:
10.1158/1535-7163.mct-10-0623
发表时间:
2010
期刊:
Molecular cancer therapeutics
影响因子:
5.7
作者:
[Tunceroglu,Ahmet, Matsuda,Michiyuki, Birge,RaymondB]
通讯作者:
Birge,RaymondB
Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.
SH3C 结构域 RT 环中酪氨酸 251 上的 Crk 磷酸化可促进 Abl 激酶反式激活。
DOI:
10.1038/onc.2011.170
发表时间:
2011
期刊:
Oncogene
影响因子:
8
作者:
[Sriram,G, Reichman,C, Tunceroglu,A, Kaushal,N, Saleh,T, Machida,K, Mayer,B, Ge,Q, Li,J, Hornbeck,P, Kalodimos,CG, Birge,RB]
通讯作者:
Birge,RB
Targeting a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer
-
批准号:10554443
-
项目类别:
-
资助金额:$47.36万
-
财政年份:2022
-
负责人:RAYMOND B BIRGE
-
依托单位:
Targeting a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer
-
批准号:10365623
-
项目类别:
-
资助金额:$50.82万
-
财政年份:2022
-
负责人:RAYMOND B BIRGE
-
依托单位:
Non-canonical signal pathway for Crk in breast cancer
-
批准号:8701004
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2012
-
负责人:RAYMOND B BIRGE
-
依托单位:
Non-canonical signal pathway for Crk in breast cancer
-
批准号:8402232
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2012
-
负责人:RAYMOND B BIRGE
-
依托单位:
Non-canonical signal pathway for Crk in breast cancer
-
批准号:9246662
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2012
-
负责人:RAYMOND B BIRGE
-
依托单位:
Non-canonical signal pathway for Crk in breast cancer
-
批准号:8509636
-
项目类别:
-
资助金额:$5.6万
-
财政年份:2012
-
负责人:RAYMOND B BIRGE
-
依托单位:
Targeting FKBP52 and Copper in Alzheimer's Disease
-
批准号:7150136
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2006
-
负责人:RAYMOND B BIRGE
-
依托单位:
Targeting FKBP52 and Copper in Alzheimer's Disease
-
批准号:7270115
-
项目类别:
-
资助金额:$21.67万
-
财政年份:2006
-
负责人:RAYMOND B BIRGE
-
依托单位:
IDENTIFICATION OF A NOVEL SIGNAL PATHWAY FOR NGF
-
批准号:6342942
-
项目类别:
-
资助金额:$26.65万
-
财政年份:1999
-
负责人:RAYMOND B BIRGE
-
依托单位:
IDENTIFICATION OF A NOVEL SIGNAL PATHWAY FOR NGF
-
批准号:6331057
-
项目类别:
-
资助金额:$9.69万
-
财政年份:1999
-
负责人:RAYMOND B BIRGE
-
依托单位:
IDENTIFICATION OF A NOVEL SIGNAL PATHWAY FOR NGF
-
批准号:2758467
-
项目类别:
-
资助金额:$27.38万
-
财政年份:1999
-
负责人:RAYMOND B BIRGE
-
依托单位:
IDENTIFICATION OF A NOVEL SIGNAL PATHWAY FOR NGF
-
批准号:6490115
-
项目类别:
-
资助金额:$26.84万
-
财政年份:1999
-
负责人:RAYMOND B BIRGE
-
依托单位:
IDENTIFICATION OF A NOVEL SIGNAL PATHWAY FOR NGF
-
批准号:6138566
-
项目类别:
-
资助金额:$15.38万
-
财政年份:1999
-
负责人:RAYMOND B BIRGE
-
依托单位:
SIGNAL TRANSDUCTION AND DIFFERENTIATION IN PC12 CELLS
-
批准号:2189977
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1994
-
负责人:RAYMOND B BIRGE
-
依托单位:
海外基金